| Execution period | November 1, 2026 to October 31, 2031 |
|---|
BSE filing, NSE: STAR. Summary written from the filing by ALFA Finder's alert engine.
Strides Pharma Science Ltd: key numbers
- Share price
- ₹957.00
- Market cap
- ₹8,822 Cr
- Revenue (annual)
- ₹4,859 Cr
- Net profit (annual)
- ₹556.2 Cr
- P/E (TTM)
- 14.3×Sector 48.6×
- Promoter holding
- 29.00%+1.09% QoQ
- FII holding
- 27.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Strides Pharma Science Ltd
All →Strides Pharma Science Annual General Meeting
Strides Pharma Science issued a postal ballot notice seeking shareholder approval to appoint Biren Gabhawala as Independent Director. Voting closes December 19, 2026.
Strides Pharma Science Earnings Call Transcript: Key Takeaways
Record Q2 revenue ₹1,430 Cr (+17% YoY), Ex-US overtakes US, but EBITDA margin fell to 17.6% on input costs; US aspiration slips beyond FY28.
Strides Pharma Science Management Change
Strides Pharma's board appointed Biren Gabhawala as Non-Executive Independent Director effective November 1, 2026, for five years. He is a Chartered Accountant with extensive audit and listed-company board experience.
- Execution
- Five-year term effective November 1, 2026
Strides Pharma Science Employee Stock Options
Strides Pharma allotted 7,500 equity shares to an employee exercising options under the Strides ESOP 2016 Plan. Paid-up capital rises to 92,180,214 shares.
Strides Pharma Science Investor Presentation: Key Takeaways
Q2FY27 revenue ₹14,297m (+17.1% YoY), EBITDA ₹2,509m (17.6% margin), reported PAT ₹1,341m (+2.0%). Ex-US revenue surpassed US for the first time; US ~$375m FY28 aspiration pushed beyond FY28.
Strides Pharma Science Results Update
Strides Pharma reported Q2FY27 revenue of ₹14,297m, up 17.1% YoY, and EBITDA of ₹2,509m, up 8.4%, in a press release. Reported PAT rose 2.0% to ₹1,341m.
Other management change announcements
All →Empower India Management Change
Empower India appointed Sumit Prajapati and Vinod Shinde as directors effective 18 November 2026. Chairman Satyawan Jankar resigned the same day.
Shrydus Industries Management Change
Shrydus Industries' board approved appointing Mrs. Saphel Vijay Champaneri as Additional Non-Executive Non-Independent Director from 18 November 2026, subject to shareholder approval. She is the wife of promoter Vijay Champaneri and holds no shares.
Machino Plastics Management Change
Machino Plastics intimated the resignation of Kazunari Yamaguchi, Suzuki-nominated Non-Executive Non-Independent Director, effective 18 November 2026. The resignation follows a change in nomination by Suzuki Motor Corporation.
Jagatjit Industries Management Change
Jagatjit Industries appointed Mr. Abhishek Kumar Singh as Chief Information Officer and Senior Management Personnel effective 18 November 2026. The appointment is a senior management change with no monetary value disclosed.
NMS Global Management Change
NMS Global's statutory auditor, Mukul Garg & Associates, resigned effective 18 November 2026. The board will recommend a new auditor for shareholder approval.
Senthil Infotek Management Change
Senthil Infotek's Company Secretary Dipak Kadel resigned with immediate effect for personal reasons. Joint MD Sunkara Srivatsava will act as compliance officer meanwhile.